Valuation: Lincoln Pharmaceuticals Limited

Market Cap 11.3B 117M 103M 95.37M 87.71M 164M 167M 1.14B 445M 5.51B 438M 429M 19.13B P/E 2024
12.6x
P/E 2025 13.4x
Enterprise Value 9.35B 96.51M 84.88M 78.86M 72.53M 136M 138M 943M 368M 4.56B 362M 354M 15.82B EV / Sales 2024
1.77x
EV / Sales 2025 1.46x
Free-Float
43.88%
Yield 2024
0.31%
Yield 2025 0.33%
1 day+1.77%
1 week-1.84%
Current month-5.55%
1 month-2.95%
3 months-3.65%
6 months+30.02%
Current year+21.95%
1 week 573.8
Extreme 573.8
604.45
1 month 573.8
Extreme 573.8
645
Current year 439.95
Extreme 439.95
770
1 year 439.95
Extreme 439.95
770
3 years 402.85
Extreme 402.85
975
5 years 255
Extreme 255
975
10 years 85.5
Extreme 85.5
975
Manager TitleAgeSince
Chief Executive Officer 72 1995-01-19
Director of Finance/CFO - 2019-03-27
Chief Tech/Sci/R&D Officer - 2025-08-28
Director TitleAgeSince
Chairman 72 1995-01-19
Chairman 82 1995-08-15
Director/Board Member 68 1995-01-19
Date Insider Type Main position Quantity % Market Cap.
6/6/24 Buy

Director

13,500 0.0674%
6/3/24 Buy

Director

15,000 0.0749%
6/3/24 Buy

Director

20,000 0.0999%
Change 5-day change 1-year change 3-year change Capi.($)
+1.77%-1.84%+7.32%+48.11% 120M
+1.97%+1.43%+48.44%+156.66% 1,037B
+1.42%+3.72%+53.32%+52.34% 615B
+1.43%+0.99%+34.83%+78.74% 448B
+5.14%+5.40%+33.75%+27.28% 326B
+1.85%+3.57%+37.09%+39.87% 293B
-0.11%+0.48%+18.87%+17.81% 264B
+0.25%-4.62%-27.66%-42.25% 216B
+1.49%-0.02%+20.14%+58.21% 198B
+0.40%-3.99%+15.23%+62.28% 162B
Average +1.56%-0.13%+24.13%+49.90% 355.76B
Weighted average by Cap. +1.73%+1.12%+35.40%+75.23%

Financials

2024 2025
Net sales 5.81B 59.95M 52.72M 48.98M 45.05M 84.48M 86M 586M 228M 2.83B 225M 220M 9.82B 6.23B 64.36M 56.6M 52.58M 48.36M 90.69M 92.32M 629M 245M 3.04B 242M 236M 10.55B
Net income 933M 9.63M 8.47M 7.87M 7.24M 13.58M 13.82M 94.13M 36.72M 455M 36.17M 35.39M 1.58B 823M 8.5M 7.48M 6.95M 6.39M 11.98M 12.2M 83.08M 32.4M 402M 31.92M 31.23M 1.39B
Net Debt -1.44B -14.84M -13.05M -12.13M -11.15M -20.91M -21.29M -145M -56.55M -701M -55.71M -54.51M -2.43B -1.96B -20.21M -17.77M -16.51M -15.19M -28.48M -28.99M -197M -77.02M -955M -75.87M -74.23M -3.31B
Logo Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.
Employees
1,853
Date Price Change Volume
26-07-23 ₹589.25 +1.77% 4,282
26-07-22 ₹579.00 -3.29% 2,381
26-07-21 ₹598.70 +0.01% 1,353
26-07-20 ₹598.65 +0.62% 1,039
26-07-17 ₹594.95 -0.89% 963
  1. Stock Market
  2. Stocks
  3. 531633 Stock